0000899243-20-023198.txt : 20200821 0000899243-20-023198.hdr.sgml : 20200821 20200821161547 ACCESSION NUMBER: 0000899243-20-023198 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200819 FILED AS OF DATE: 20200821 DATE AS OF CHANGE: 20200821 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stylli Harry CENTRAL INDEX KEY: 0001329344 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39334 FILM NUMBER: 201123569 MAIL ADDRESS: STREET 1: 3595 JOHN HOPKINS CT CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PROGENITY, INC. CENTRAL INDEX KEY: 0001580063 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 273950390 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4330 LA JOLLA VILLAGE DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92122 BUSINESS PHONE: 855-293-2639 MAIL ADDRESS: STREET 1: 4330 LA JOLLA VILLAGE DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92122 FORMER COMPANY: FORMER CONFORMED NAME: ASCENDANT MDX, INC. DATE OF NAME CHANGE: 20130625 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-08-19 0 0001580063 PROGENITY, INC. PROG 0001329344 Stylli Harry C/O PROGENITY, INC. 4330 LA JOLLA VILLAGE DRIVE, SUITE 200 SAN DIEGO CA 92122 1 1 1 0 Chairman & CEO Common Stock 2020-08-19 4 P 0 10000 8.94 A 14463969 D Stock Option (Right to Buy) 9.76 2020-02-05 4 A 0 478148 0.00 A 2030-02-05 Common Stock 478148 478148 D The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.87 to $8.96 inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range. Includes 239,074 restricted stock units ("RSUs"), 24,900 of which have vested as of June 18, 2020. Subject to the Reporting Person's continued service to the Issuer, all unvested RSUs will vest in semi-annual installments beginning on February 15, 2021 and ending on August 15, 2024. The Reporting Person's Form 3 filed on June 18, 2020 (the "Form 3") reported a vested amount of 19,922 and a final vesting date of February 15, 2024 in error. This option represents the right to purchase a total of 478,148 shares of the Issuer's common stock, 49,805 of which have vested as of June 18, 2020, with the remaining shares vesting in equal monthly installments through January 15, 2024, subject to the Reporting Person's continued service to the Issuer. The Form 3 reported a vesting schedule of one quarter vesting on February 5, 2021, with the remaining three quarters vesting in equal monthly installments for the following three years, in error. /s/ Will Pridgen, Attorney-in-Fact for Harry Stylli 2020-08-21